Caracterização clínica, epidemiológica e sobrevida de pacientes portadores de hepatite c em um serviço referência de Teresina, PI

Detalhes bibliográficos
Ano de defesa: 2016
Autor(a) principal: Xavier, Yara Vanessa Trindade
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Não Informado pela instituição
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: http://www.repositorio.ufc.br/handle/riufc/17970
Resumo: Hepatitis C is currently the leading cause of chronic liver disease, cirrhosis and carcinoma hepatocelular.Tratou is a descriptive, cross-sectional, quantitative, retrospective (2000 - 2014) in patients with chronic HCV infection originating outpatient consultation of HEMOPI , PI. Patient data were collected with a confirmed diagnosis of hepatitis C, of 155 medical records for medical care in order to characterized them for clinical, epidemiological and survival. Then they were related criteria found by gender and age group, obtaining the following results: In men is greater the negative viral load and that remain under assessment; genotype 3 appear as the predominant, followed by 1b and 2, the site of infection identification prevails the use of vitamin and intravenous drug, the greater is the degree of fibrosis portal fibrosis F1-F3 and liver and histopathologic activity A1- light and A4-severe, and higher mean viral load. In women it is identified greater number of deaths; genotype 1a; blood transfusion and surgery as a form of contagion; F2 fibrosis in the liver portal fibrosis with rare septal fibrosis F0-F4 or absence of fibrosis and histological activity and moderate A2-A0 absent. In the age group of between 29-59 years of age is higher the dropout rate of treatment; the predominant genotype is 3, followed by 1a; in relation to the site of contagion, transfusion and intravenous drug use; the degree of liver fibrosis, and F4 and F3-F0 no fibrosis; in the analysis of inflammatory activity of severe liver A3, and also A0-away. In patients 60 years of age or older identifies the highest number of deaths and staying in treatment assessment; is the predominant genotype 1b followed by 2; the form of contagion by the use of vitamin and performing some surgery; It is greater the degree of fibrosis in liver fibrosis, portal F1 and histopathological features activity A1-A2-light, moderate and has a higher average viral load. The search results reveal difficulties encountered in manual recording information related to treatment, which leads to reflection of the importance of adequately monitor the follow-up of patients because some do not heal, they resort to transplantation or relapse, further increasing public spending on health.